In silico design of a multi-epitope vaccine targeting DENV-1 and DENV-3

Nature·Jan 16

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers have designed a multi-epitope vaccine targeting dengue viruses, specifically DENV-1 and DENV-3, using in silico methods. The approach is part of a broader trend of using immunoinformatic strategies to design vaccines against various diseases, including Zika, HIV, and rotavirus. The development of multi-epitope vaccines is being explored for several viruses, with some studies focusing on specific serotypes or proteins.

Full coverage

Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses

Nature·Mar 31

Immunoinformatic-driven design and evaluation of multi-epitope mRNA vaccine targeting HIV-1 gp120

Frontiers·May 13

In silico design of novel multi-epitope peptide vaccine against Neospora caninum induced cattle abortion targeting extracellular GRA2 and Nc-p43 protein

Nature·Nov 26

Super epitope dengue vaccine instigated serotype independent immune protection in-silico

ScienceDirect.com·Jul 11

Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach

Frontiers·Nov 16

In silico design and immunoinformatics assessment of a multiepitope vaccine targeting borealpox virus

Nature·Jan 20

Multi-epitope peptide vaccines targeting dengue virus serotype 2 created via immunoinformatic analysis

Nature·Jul 31

Immunoinformatics-driven design of a multi-epitope vaccine targeting neonatal rotavirus with focus on outer capsid proteins VP4 and VP7 and non structural proteins NSP2 and NSP5

Nature·Apr 7

View original report at Nature ↗

Fetching the latest headlines…